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Purpose of the study
To determine the prevalence of CRF and MS in an HIV-
infected population, to analyse the risk factors for the
development of MS, and to estimate the cardiovascular
risk (CVR) at 10 years.
Methods
Multicenter, cross-sectional study of all outpatients
attended in five hospitals in southern Spain from March
2007 – August 2007. Demographic features, blood pres-
sure, tobacco use, lipid profile, diabetes mellitus (DM),
personal and family history of coronary heart disease
(CHD) were collected. MS was diagnosed according to
NCEP. CVR: Framingham score. High CVR: >10% at 10
years. Statistics program: SPSS.
Summary of results
1,155 patients were included; mean age 44 (39–49) years,
CD4 count 544 (336–711) cells/μl, and 86% on ART
(85.5% with VL<50 cop/mL). CRF (%): male 76, smokers
59, family history of CHD 10.6, hypertension (HT) 10.6,
DM 9.4, prior CHD 3.5. A total of 155 (14.3%) patients fit
the criteria of MS: hypertriglyceridemia (HTG) 88.3, low
HDL-C levels 78.7, HT 61.9, hyperglycaemia 60.6, and
abdominal obesity 41.2%. Use of lipid-lowering drugs
(24.5 vs. 11.3%, p < 0.0001), antidiabetics (18.0 vs. 1.7%,
p < 0.0001), antihypertensives (21.2 vs. 5.8%, p <
0.0001), and anti-aggregants (7.7 vs. 3.6, p < 0.02) were
more common in cases with MS. MS was present in 15.5%
of patients on PI and 13.7% on ITINAN (ns); HTG and
low HDL-C were more frequent in subjects on PI (50.4 vs.
34.9% and 52.1 vs. 31.6%; p < 0.0001, respectively), and
HT and hyperglycaemia in those on NNRTI (26.8 vs.
17.5%, and 20.1 vs. 14.0%; p = 0.001, respectively). Age
was the only factor associated with MS in multivariate
analysis (OR 4.7; CI 95% 4.6–4.8, for each 5 years more).
The mean global CVR at 10 years was 6.4% (IQR: 1–9),
higher in cases with MS (10.9 vs. 5.6%, p < 0.0001), and
similar in PI and NNRTI groups (6.7 vs 6.6%; ns).
Conclusion
Tobacco use was the most frequent CRF. In this cohort,
the prevalence of MS was lower than in others, and similar
to that in general Spanish population, but with a different
distribution of its components, predominating HTG and
low HDL-C levels. Although the prevalence of MS and
mean CVR were similar among patients on PI and those
on NNRTI, lipid abnormalities were more frequent with
PI, and HT and hyperglycaemia with NNRTI. MS was not
associated with any HIV-specific factors, but only with
age.
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